Schonfeld Strategic Advisors LLC Edgewise Therapeutics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 268,509 shares of EWTX stock, worth $3.63 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
268,509
Previous 545,546
50.78%
Holding current value
$3.63 Million
Previous $14.6 Million
50.76%
% of portfolio
0.05%
Previous 0.11%
Shares
8 transactions
Others Institutions Holding EWTX
# of Institutions
221Shares Held
98.2MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$203 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$121 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$83.3 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$81.4 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$67.7 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $855M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...